No immediate trading implications; the dissent levels for two directors (7.78% and 16.24% against) are worth monitoring for potential future activist interest, but no near-term catalyst is indicated.
Price Chart
Executive Summary
Satellos Bioscience filed a 6-K reporting voting results from its June 17, 2026 annual meeting. All nine director nominees were elected, with Iris Loew-Friedrich receiving 16.24% votes against (notable dissent), and auditor PricewaterhouseCoopers was reappointed with 98.69% approval. The filing is a routine annual meeting update with no material financial or operational changes.
Key Facts
- All nine director nominees were elected; Iris Loew-Friedrich received 83.76% for and 16.24% against—the highest dissent among nominees.
- Auditor PricewaterhouseCoopers LLP was reappointed with 98.69% of votes in favor.
- Approximately 55.33% of issued and outstanding shares were represented at the meeting.
- Director Stephanie Brown received 92.22% for and 7.78% against.
- Other directors received over 99% support.
Financial Impact
Not specified
Risk Factors
- Shareholder dissent for Iris Loew-Friedrich (16.24%) and Stephanie Brown (7.78%) may signal governance concerns.
- Low shareholder turnout (55.33%) could indicate limited engagement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004176 |
| Exhibit: exh_991.htm | 0001171843-26-004176 |
| Document: 0001171843-26-004176-index-headers.html | 0001171843-26-004176 |
| Document: 0001171843-26-004176-index.html | 0001171843-26-004176 |
| Document: 0001171843-26-004176.txt | 0001171843-26-004176 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $6.42 | awaiting T+20 | — | $6.88 (+7.17%) |
Oct 21, 2026 6d ago | 6-K | $6.70 | awaiting T+20 | — | $6.88 (+2.69%) |
Oct 5, 2026 22d ago | 6-K | $8.05 | awaiting T+20 | — | $6.88 (−14.53%) |
Sep 30, 2026 27d ago | 6-K | $8.50 | awaiting T+20 | — | $6.88 (−19.06%) |
Sep 30, 2026 27d ago | Press Release | $8.50 | awaiting T+20 | — | $6.88 (−19.06%) |
Sep 24, 2026 4w ago | 6-K | $8.71 $6.63 | ▼ −23.94% | ▼ −23.52% | $6.88 (−21.01%) |
Sep 24, 2026 4w ago | Press Release | $8.71 $6.63 | ▼ −23.94% | ▼ −23.52% | $6.88 (−21.01%) |
Sep 15, 2026 6w ago | 6-K | $9.36 $7.04 | ▼ −24.79% | ▼ −27.51% | $6.88 (−26.50%) |
Sep 9, 2026 6w ago | 6-K | $10.02 $7.63 | ▼ −23.85% | ▼ −26.05% | $6.88 (−31.34%) |
Sep 1, 2026 8w ago | 6-K | $9.08 $8.69 | ▼ −4.30% | ▼ −5.48% | $6.88 (−24.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers